 |
 |
 |
| 1987 |
 Established Life Science Business Division (SK Chemicals)
Starting Life Science Business by M&A of SamShin
Pharmaceuticals Ltd. |
| 1988 |
Established Sunkyong Pharmaceuticals Ltd. |
| 1989 |
Constructed Life Science Research Center |
| 1992 |
Launched GINEXIN Tab. (Blood Circulating Enhancer) |
|
|
 |
 |
|
| 1996 |
Launched TRAST Patch (World 1st NSAID patch, Anti-arthritis
patch)
Launched LEVOPRIDE Tab. (Gastro-prokinetic drug) |
| 1998 |
Renamed to SK Pharma |
| 1999 |
Launched SUNPLA Inj. (Korea 1st New Drug, Anti-cancer agent)
Passed European GMP Inspection in OMED (Proton Pump
Inhibitor) |
|
|
 |
 |
|
| 2001 |
Acquired access to Bio-pharmaceutical segment
Vaccine and Blood preparation
through the acquisition of Dong Shin Pharmaceuticals Ltd. |
| 2002 |
Launched JOINS Tab. (Korea’s 1st Natural New Drug) |
| 2003 |
Passed Australian GMP Inspection of JOINS |
| 2004 |
Launched SKAD Tab. (Korea’s 1st generic of Amlodipine) |
| 2005 |
SK Chemicals merged with SK Pharma
Established SK Chemicals Life Science Division |
|
